Efficacy of first-line tocilizumab therapy in early polymyalgia rheumatica: a prospective longitudinal study

BACKGROUND: Glucocorticoids are the cornerstone treatment of polymyalgia rheumatica (PMR) but induce adverse events. OBJECTIVES: To evaluate the efficacy and safety of first-line tocilizumab in PMR. METHODS: In a prospective open-label study (ClinicalTrials.gov: NCT01713842), 20 glucocorticoid-free...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Ann Rheum Dis
Autores principales: Devauchelle-Pensec, Valérie, Berthelot, Jean Marie, Cornec, Divi, Renaudineau, Yves, Marhadour, Thierry, Jousse-Joulin, Sandrine, Querellou, Solène, Garrigues, Florent, De Bandt, Michel, Gouillou, Maelenn, Saraux, Alain
Formato: Artigo
Lenguaje:Inglês
Publicado: BMJ Publishing Group 2016
Materias:
Clinical and Epidemiological Research
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC4975852/
https://ncbi.nlm.nih.gov/pubmed/26929219
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/annrheumdis-2015-208742
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares